Hypertension (Newton Laboratories, Inc.)


Welcome to the PulseAid listing for the Hypertension drug offered from Newton Laboratories, Inc.. This Adrenergic alpha-Agonists [MoA],Adrenergic beta-Agonists [MoA],alpha-Adrenergic Agonist [EPC],beta-Adrenergic Agonist [EPC],Catecholamine [EPC],Catecholamines [Chemical/Ingredient],Standardized Chemical Allergen [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Allergens [Chemical/Ingredient],Nitrate Vasodilator [EPC],Nitrates [Chemical/Ingredient],Vasodilation [PE],Non-Standardized Plant Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Allergens [Chemical/Ingredient],Plant Proteins [Chemical/Ingredient],Seed Storage Proteins [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Newton Laboratories, Inc.
NON-PROPRIETARY NAME: Elaps corallinus, Adrenalinum, Arsenicum iodatum , Aur. met., Baryta carb., Bryonia, Cactus, Chelidonium majus, Cinchona, Crotalus horridus, Digitalis, Glonoinum, Kali carb., Kali iod ., Lachesis , Na
SUBSTANCE NAME: MICRURUS CORALLINUS VENOM; EPINEPHRINE; ARSENIC TRIIODIDE; GOLD; BARIUM CARBONATE; BRYONIA ALBA ROOT; SELENICEREUS GRANDIFLORUS STEM; CHELIDONIUM MAJUS; CINCHONA OFFICINALIS BARK; CROTALUS HORRIDUS HO
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Adrenergic alpha-Agonists [MoA],Adrenergic beta-Agonists [MoA],alpha-Adrenergic Agonist [EPC],beta-Adrenergic Agonist [EPC],Catecholamine [EPC],Catecholamines [Chemical/Ingredient],Standardized Chemical Allergen [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Allergens [Chemical/Ingredient],Nitrate Vasodilator [EPC],Nitrates [Chemical/Ingredient],Vasodilation [PE],Non-Standardized Plant Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Allergens [Chemical/Ingredient],Plant Proteins [Chemical/Ingredient],Seed Storage Proteins [Chemical/Ingredient]
ROUTE: ORAL
DOSAGE FORM: PELLET
MARKETING CATEGORY NAME: UNAPPROVED HOMEOPATHIC
START MARKETING DATE: 2011-06-01
END MARKETING DATE: 0000-00-00


Hypertension HUMAN PRESCRIPTION DRUG Details:

Item DescriptionHypertension from Newton Laboratories, Inc.
LABELER NAME: Newton Laboratories, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 30; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 3; 3([hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; )
START MARKETING DATE: 2011-06-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 55714-4425_d0ae71ca-571d-8cd5-9542-93ade77dc7bc
PRODUCT NDC: 55714-4425
APPLICATION NUMBER:

Other MICRURUS CORALLINUS VENOM; EPINEPHRINE; ARSENIC TRIIODIDE; GOLD; BARIUM CARBONATE; BRYONIA ALBA ROOT; SELENICEREUS GRANDIFLORUS STEM; CHELIDONIUM MAJUS; CINCHONA OFFICINALIS BARK; CROTALUS HORRIDUS HO Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Newton Laboratories, Inc.Hypertension